Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans
- 1 September 2000
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 23 (8) , 493-495
- https://doi.org/10.1007/bf03343763
Abstract
An endogenous ligand for the GH secretagogue-receptor (GHS-R) has been recently purified from rat and human stomach and named Ghrelin. It has been demonstrated that Ghrelin specifically stimulates GH secretion from rat pituitary cells in culture as well as in rats in vivo. In this preliminary study, in 4 normal adults [age (mean±SE): 28.6±3.5 yr; body mass index (BMI): 22.3±2.1 kg/m2] we administered 1.0 μg/kg Ghrelin or GHRH-29 to compare their GH-releasing activities in humans. In all subjects Ghrelin induced a prompt, marked and long-lasting increase in circulating GH levels (peak: 107.9±26.1 μg/l; AUC: 6503.1±1632.7 μg/l/h). The GH response to Ghrelin was clearly higher (p<0.05) than that after GHRH (peak: 22.3±4.5 μg/l; AUC: 1517.5±338.4 μg/l/h). In conclusion, this preliminary study shows that Ghrelin exerts a strong stimulatory effect on GH secretion in humans releasing more GH than GHRH.Keywords
This publication has 9 references indexed in Scilit:
- Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulationActa Endocrinologica, 2000
- Growth hormone-releasing peptides and the cardiovascular system.2000
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999
- Hormonal Activities of Growth Hormone Secretagogues (GHS) across Human LifespanPublished by Elsevier ,1999
- Synthetic peptides and their non-peptidyl mimetics in endocrinology: From synthesis to clinical perspectivesJournal of Endocrinological Investigation, 1998
- Peptidomimetic Regulation of Growth Hormone SecretionEndocrine Reviews, 1997
- Growth hormone-releasing peptidesActa Endocrinologica, 1997
- Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.Journal of Clinical Endocrinology & Metabolism, 1994
- Dose-Response Relationships for the Effects of Growth Hormone-Releasing Factor-(1–44)-NH2in Young Adult Men and WomenJournal of Clinical Endocrinology & Metabolism, 1984